Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urinary Tract Infections | 31 | 2024 | 802 | 7.130 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 20 | 2021 | 698 | 3.940 |
Why?
|
Staphylococcal Infections | 20 | 2023 | 1407 | 3.420 |
Why?
|
Surgical Wound Infection | 14 | 2024 | 1529 | 2.810 |
Why?
|
Anti-Bacterial Agents | 40 | 2024 | 7406 | 2.810 |
Why?
|
Antibiotic Prophylaxis | 11 | 2019 | 637 | 2.730 |
Why?
|
Cystitis | 10 | 2023 | 95 | 2.430 |
Why?
|
Carrier State | 8 | 2021 | 523 | 2.120 |
Why?
|
Bacteriuria | 5 | 2019 | 102 | 1.920 |
Why?
|
Cross Infection | 17 | 2024 | 1422 | 1.820 |
Why?
|
Anti-Infective Agents | 8 | 2020 | 983 | 1.740 |
Why?
|
Vancomycin | 8 | 2022 | 503 | 1.670 |
Why?
|
Drug Resistance, Multiple, Bacterial | 10 | 2018 | 587 | 1.540 |
Why?
|
Clostridium Infections | 7 | 2022 | 558 | 1.520 |
Why?
|
Infection Control | 8 | 2021 | 982 | 1.190 |
Why?
|
Anti-Infective Agents, Urinary | 4 | 2011 | 28 | 1.190 |
Why?
|
Pyuria | 2 | 2020 | 30 | 1.100 |
Why?
|
Mass Screening | 8 | 2021 | 5429 | 0.970 |
Why?
|
Escherichia coli Infections | 6 | 2016 | 518 | 0.930 |
Why?
|
Diagnostic Tests, Routine | 3 | 2020 | 787 | 0.920 |
Why?
|
Hospitals, Veterans | 10 | 2021 | 395 | 0.920 |
Why?
|
Pyelonephritis | 5 | 2011 | 75 | 0.920 |
Why?
|
Nitrofurantoin | 3 | 2023 | 18 | 0.880 |
Why?
|
Patients' Rooms | 2 | 2014 | 62 | 0.870 |
Why?
|
Acute Kidney Injury | 4 | 2019 | 1924 | 0.830 |
Why?
|
Catheter-Related Infections | 3 | 2016 | 273 | 0.830 |
Why?
|
Nasal Cavity | 3 | 2014 | 304 | 0.780 |
Why?
|
beta-Lactams | 2 | 2017 | 155 | 0.770 |
Why?
|
Residential Facilities | 1 | 2021 | 42 | 0.770 |
Why?
|
Drug Resistance, Bacterial | 8 | 2023 | 1048 | 0.760 |
Why?
|
Asymptomatic Infections | 3 | 2019 | 131 | 0.700 |
Why?
|
Nasal Mucosa | 3 | 2012 | 416 | 0.700 |
Why?
|
Health Personnel | 6 | 2023 | 3335 | 0.700 |
Why?
|
Common Cold | 1 | 2020 | 63 | 0.690 |
Why?
|
Soft Tissue Infections | 3 | 2020 | 168 | 0.660 |
Why?
|
Urinalysis | 4 | 2024 | 368 | 0.660 |
Why?
|
Antibodies, Viral | 2 | 2021 | 3156 | 0.650 |
Why?
|
Natural Language Processing | 5 | 2016 | 1163 | 0.640 |
Why?
|
Immunoglobulin G | 2 | 2021 | 4544 | 0.620 |
Why?
|
Cross Reactions | 1 | 2020 | 817 | 0.610 |
Why?
|
Lactobacillus | 2 | 2012 | 212 | 0.610 |
Why?
|
Nasopharynx | 1 | 2020 | 401 | 0.570 |
Why?
|
Mupirocin | 3 | 2013 | 55 | 0.550 |
Why?
|
Orthopedic Procedures | 2 | 2024 | 1265 | 0.540 |
Why?
|
Ultrasound, High-Intensity Focused, Transrectal | 1 | 2015 | 6 | 0.520 |
Why?
|
Sulfanilamides | 1 | 2015 | 14 | 0.520 |
Why?
|
Veterans | 8 | 2023 | 2649 | 0.520 |
Why?
|
Population Surveillance | 3 | 2020 | 2598 | 0.520 |
Why?
|
Fosfomycin | 1 | 2015 | 24 | 0.520 |
Why?
|
Bacterial Infections | 3 | 2017 | 1391 | 0.500 |
Why?
|
Electronic Health Records | 9 | 2020 | 4811 | 0.490 |
Why?
|
Nose | 3 | 2013 | 521 | 0.460 |
Why?
|
Housekeeping, Hospital | 1 | 2014 | 17 | 0.460 |
Why?
|
Environmental Microbiology | 1 | 2014 | 47 | 0.450 |
Why?
|
Drug Resistance, Microbial | 2 | 2015 | 825 | 0.450 |
Why?
|
Education, Professional | 1 | 2014 | 52 | 0.440 |
Why?
|
Computer Systems | 1 | 2015 | 470 | 0.440 |
Why?
|
beta-Lactamases | 1 | 2015 | 304 | 0.440 |
Why?
|
Boston | 9 | 2021 | 9327 | 0.440 |
Why?
|
Disease Outbreaks | 3 | 2022 | 1749 | 0.440 |
Why?
|
Urinary Tract | 2 | 2015 | 313 | 0.430 |
Why?
|
Reminder Systems | 2 | 2019 | 388 | 0.430 |
Why?
|
Ciprofloxacin | 4 | 2023 | 312 | 0.430 |
Why?
|
Occupational Diseases | 1 | 2021 | 1490 | 0.420 |
Why?
|
Pacemaker, Artificial | 4 | 2020 | 807 | 0.420 |
Why?
|
Humans | 108 | 2024 | 761596 | 0.410 |
Why?
|
Hysterectomy | 1 | 2018 | 857 | 0.410 |
Why?
|
Staphylococcus aureus | 3 | 2023 | 1457 | 0.410 |
Why?
|
United States Department of Veterans Affairs | 6 | 2021 | 928 | 0.410 |
Why?
|
Vaccinium macrocarpon | 1 | 2012 | 11 | 0.400 |
Why?
|
Luminescent Measurements | 1 | 2014 | 342 | 0.400 |
Why?
|
Molecular Typing | 1 | 2012 | 116 | 0.390 |
Why?
|
Algorithms | 5 | 2021 | 14033 | 0.390 |
Why?
|
Skin Diseases, Bacterial | 1 | 2012 | 68 | 0.390 |
Why?
|
Bacteremia | 2 | 2016 | 980 | 0.390 |
Why?
|
Urinary Catheterization | 1 | 2012 | 193 | 0.390 |
Why?
|
Escherichia coli | 7 | 2023 | 4217 | 0.390 |
Why?
|
Disinfection | 1 | 2014 | 211 | 0.390 |
Why?
|
Surgical Mesh | 4 | 2021 | 311 | 0.380 |
Why?
|
Veterans Health | 2 | 2019 | 215 | 0.370 |
Why?
|
Microbial Sensitivity Tests | 6 | 2023 | 1936 | 0.350 |
Why?
|
Staphylococcal Skin Infections | 1 | 2011 | 78 | 0.350 |
Why?
|
Prosthesis-Related Infections | 4 | 2020 | 487 | 0.350 |
Why?
|
Chlorhexidine | 2 | 2011 | 160 | 0.340 |
Why?
|
Vaccination | 1 | 2021 | 3384 | 0.330 |
Why?
|
Azepines | 1 | 2011 | 329 | 0.330 |
Why?
|
Health Services Research | 3 | 2017 | 1812 | 0.320 |
Why?
|
Lactones | 1 | 2011 | 317 | 0.320 |
Why?
|
Inappropriate Prescribing | 1 | 2011 | 211 | 0.310 |
Why?
|
Secondary Prevention | 3 | 2024 | 1475 | 0.300 |
Why?
|
Polymerase Chain Reaction | 5 | 2021 | 6075 | 0.300 |
Why?
|
Female | 51 | 2024 | 392705 | 0.290 |
Why?
|
Asymptomatic Diseases | 1 | 2011 | 588 | 0.290 |
Why?
|
Decision Support Techniques | 1 | 2017 | 1998 | 0.290 |
Why?
|
Adenosine Triphosphate | 1 | 2014 | 1989 | 0.290 |
Why?
|
Hernia, Ventral | 2 | 2021 | 218 | 0.290 |
Why?
|
Surgical Procedures, Operative | 1 | 2019 | 1924 | 0.290 |
Why?
|
Disease Transmission, Infectious | 2 | 2014 | 560 | 0.280 |
Why?
|
Middle Aged | 37 | 2024 | 220921 | 0.280 |
Why?
|
Methicillin Resistance | 1 | 2007 | 198 | 0.280 |
Why?
|
Risk Factors | 19 | 2024 | 74213 | 0.270 |
Why?
|
Beverages | 1 | 2012 | 821 | 0.270 |
Why?
|
Myeloid Cells | 1 | 2011 | 823 | 0.270 |
Why?
|
Community-Acquired Infections | 2 | 2007 | 469 | 0.260 |
Why?
|
Disease Management | 4 | 2019 | 2508 | 0.260 |
Why?
|
Recurrence | 8 | 2024 | 8466 | 0.250 |
Why?
|
Sepsis | 2 | 2020 | 2585 | 0.250 |
Why?
|
Aged | 30 | 2021 | 169310 | 0.250 |
Why?
|
Bacterial Adhesion | 1 | 2006 | 306 | 0.250 |
Why?
|
United States | 21 | 2024 | 72340 | 0.250 |
Why?
|
Male | 39 | 2024 | 360846 | 0.240 |
Why?
|
Incidence | 9 | 2021 | 21355 | 0.240 |
Why?
|
Rectum | 2 | 2010 | 892 | 0.240 |
Why?
|
Preoperative Period | 2 | 2019 | 551 | 0.220 |
Why?
|
Retrospective Studies | 19 | 2023 | 80647 | 0.220 |
Why?
|
Acute Disease | 7 | 2017 | 7237 | 0.220 |
Why?
|
Fluoroquinolones | 2 | 2015 | 307 | 0.210 |
Why?
|
Postoperative Complications | 5 | 2020 | 15633 | 0.210 |
Why?
|
Hypersensitivity | 2 | 2023 | 1171 | 0.210 |
Why?
|
Piperidines | 1 | 2011 | 1656 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3086 | 0.210 |
Why?
|
Biological Products | 1 | 2012 | 914 | 0.210 |
Why?
|
Massachusetts | 3 | 2021 | 8833 | 0.200 |
Why?
|
Vagina | 2 | 2006 | 838 | 0.190 |
Why?
|
Lactams | 1 | 2022 | 156 | 0.190 |
Why?
|
Hospitals | 5 | 2022 | 3883 | 0.190 |
Why?
|
Aged, 80 and over | 16 | 2021 | 58984 | 0.190 |
Why?
|
Leucine | 1 | 2022 | 548 | 0.180 |
Why?
|
Adult | 24 | 2023 | 221210 | 0.180 |
Why?
|
Blood Component Transfusion | 1 | 2021 | 142 | 0.180 |
Why?
|
Proline | 1 | 2022 | 457 | 0.180 |
Why?
|
Ritonavir | 1 | 2022 | 329 | 0.180 |
Why?
|
Drug Prescriptions | 2 | 2020 | 1670 | 0.170 |
Why?
|
Nursing Homes | 4 | 2023 | 1082 | 0.170 |
Why?
|
Multivariate Analysis | 4 | 2014 | 12059 | 0.170 |
Why?
|
Long-Term Care | 2 | 2021 | 633 | 0.170 |
Why?
|
Health Facility Environment | 1 | 2019 | 32 | 0.160 |
Why?
|
Cefazolin | 1 | 2019 | 94 | 0.160 |
Why?
|
Immunization, Passive | 1 | 2021 | 616 | 0.160 |
Why?
|
Documentation | 2 | 2016 | 897 | 0.160 |
Why?
|
Enterobacteriaceae Infections | 2 | 2013 | 188 | 0.160 |
Why?
|
Patient Identification Systems | 1 | 2019 | 75 | 0.160 |
Why?
|
Defibrillators, Implantable | 2 | 2020 | 1490 | 0.160 |
Why?
|
Skin | 1 | 2012 | 4484 | 0.160 |
Why?
|
Device Removal | 2 | 2021 | 630 | 0.150 |
Why?
|
Bacteriological Techniques | 1 | 2019 | 275 | 0.150 |
Why?
|
Plasma | 1 | 2021 | 586 | 0.150 |
Why?
|
Hernia, Inguinal | 1 | 2020 | 220 | 0.150 |
Why?
|
Predictive Value of Tests | 4 | 2016 | 15266 | 0.150 |
Why?
|
Hospitalization | 5 | 2021 | 10721 | 0.150 |
Why?
|
Personnel, Hospital | 1 | 2019 | 285 | 0.140 |
Why?
|
Cohort Studies | 8 | 2024 | 41495 | 0.140 |
Why?
|
Arthroplasty | 1 | 2019 | 313 | 0.140 |
Why?
|
Nitriles | 1 | 2022 | 971 | 0.140 |
Why?
|
Time Factors | 8 | 2024 | 39969 | 0.140 |
Why?
|
Protective Clothing | 1 | 2017 | 103 | 0.140 |
Why?
|
Confidence Intervals | 2 | 2014 | 2927 | 0.140 |
Why?
|
Skilled Nursing Facilities | 1 | 2021 | 398 | 0.130 |
Why?
|
Propensity Score | 1 | 2024 | 1913 | 0.130 |
Why?
|
Klebsiella | 1 | 2015 | 49 | 0.130 |
Why?
|
Pneumonia | 2 | 2020 | 2143 | 0.130 |
Why?
|
Drug Combinations | 2 | 2022 | 2048 | 0.130 |
Why?
|
Specimen Handling | 1 | 2020 | 702 | 0.130 |
Why?
|
Laboratories, Hospital | 1 | 2017 | 192 | 0.120 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2011 | 3615 | 0.120 |
Why?
|
Hand | 2 | 2011 | 903 | 0.120 |
Why?
|
Empirical Research | 1 | 2015 | 120 | 0.120 |
Why?
|
Probability | 1 | 2020 | 2477 | 0.120 |
Why?
|
Patient Education as Topic | 2 | 2017 | 2319 | 0.120 |
Why?
|
Animal Husbandry | 1 | 2015 | 64 | 0.120 |
Why?
|
Gentamicins | 1 | 2015 | 243 | 0.120 |
Why?
|
Referral and Consultation | 2 | 2017 | 3600 | 0.120 |
Why?
|
Ceftriaxone | 1 | 2015 | 175 | 0.120 |
Why?
|
Epithelial Cells | 1 | 2006 | 3677 | 0.120 |
Why?
|
Drug Therapy, Combination | 2 | 2015 | 6312 | 0.120 |
Why?
|
Remote Consultation | 1 | 2017 | 237 | 0.120 |
Why?
|
Prevalence | 6 | 2019 | 15733 | 0.120 |
Why?
|
Electronics, Medical | 1 | 2014 | 72 | 0.110 |
Why?
|
Research | 2 | 2019 | 1982 | 0.110 |
Why?
|
Patient Isolation | 1 | 2014 | 100 | 0.110 |
Why?
|
Cell Differentiation | 1 | 2011 | 11530 | 0.110 |
Why?
|
Pilot Projects | 2 | 2017 | 8633 | 0.110 |
Why?
|
Treatment Outcome | 10 | 2023 | 64685 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2019 | 1386 | 0.110 |
Why?
|
Gram-Negative Bacteria | 1 | 2014 | 272 | 0.110 |
Why?
|
Leukocidins | 1 | 2012 | 18 | 0.100 |
Why?
|
Catheters, Indwelling | 1 | 2015 | 426 | 0.100 |
Why?
|
Emergency Service, Hospital | 2 | 2019 | 7879 | 0.100 |
Why?
|
Sentinel Surveillance | 1 | 2014 | 291 | 0.100 |
Why?
|
New England | 2 | 2013 | 1054 | 0.100 |
Why?
|
Colony Count, Microbial | 1 | 2013 | 330 | 0.100 |
Why?
|
Guideline Adherence | 2 | 2019 | 2220 | 0.100 |
Why?
|
Exotoxins | 1 | 2012 | 121 | 0.100 |
Why?
|
Intensive Care Units | 3 | 2017 | 3744 | 0.100 |
Why?
|
Nasopharyngeal Diseases | 1 | 2011 | 26 | 0.100 |
Why?
|
Feces | 1 | 2018 | 1497 | 0.100 |
Why?
|
Heterocyclic Compounds, Bridged-Ring | 1 | 2011 | 1 | 0.100 |
Why?
|
Meat | 1 | 2015 | 584 | 0.100 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 935 | 0.100 |
Why?
|
Interpersonal Relations | 1 | 2019 | 1436 | 0.100 |
Why?
|
Automation | 1 | 2014 | 586 | 0.100 |
Why?
|
Penicillin-Binding Proteins | 1 | 2012 | 148 | 0.090 |
Why?
|
Treatment Failure | 1 | 2017 | 2643 | 0.090 |
Why?
|
Hospitals, Public | 1 | 2012 | 202 | 0.090 |
Why?
|
Quality Control | 1 | 2014 | 832 | 0.090 |
Why?
|
HL-60 Cells | 1 | 2011 | 363 | 0.090 |
Why?
|
Program Development | 1 | 2017 | 1297 | 0.090 |
Why?
|
Aerosols | 2 | 2024 | 635 | 0.090 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2011 | 360 | 0.090 |
Why?
|
Odds Ratio | 2 | 2014 | 9647 | 0.090 |
Why?
|
Molecular Epidemiology | 1 | 2012 | 469 | 0.090 |
Why?
|
Poisson Distribution | 1 | 2011 | 504 | 0.090 |
Why?
|
Survival Analysis | 2 | 2021 | 10090 | 0.090 |
Why?
|
Outpatients | 2 | 2016 | 1597 | 0.090 |
Why?
|
Antiviral Agents | 1 | 2022 | 3060 | 0.090 |
Why?
|
Diagnosis, Differential | 2 | 2017 | 12973 | 0.080 |
Why?
|
Receptors, GABA | 1 | 2011 | 313 | 0.080 |
Why?
|
Proportional Hazards Models | 2 | 2021 | 12463 | 0.080 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 819 | 0.080 |
Why?
|
Oropharynx | 1 | 2010 | 138 | 0.080 |
Why?
|
Travel | 1 | 2015 | 796 | 0.080 |
Why?
|
Communicable Diseases | 1 | 2017 | 875 | 0.080 |
Why?
|
Candidiasis | 1 | 2011 | 365 | 0.080 |
Why?
|
Catheters | 1 | 2011 | 427 | 0.080 |
Why?
|
Young Adult | 5 | 2021 | 59260 | 0.080 |
Why?
|
Sensitivity and Specificity | 2 | 2014 | 14665 | 0.070 |
Why?
|
Wounds and Injuries | 2 | 2011 | 2492 | 0.070 |
Why?
|
Risk Adjustment | 1 | 2011 | 600 | 0.070 |
Why?
|
Placebos | 1 | 2012 | 1667 | 0.070 |
Why?
|
Prostate | 1 | 2015 | 1773 | 0.070 |
Why?
|
Adolescent | 7 | 2017 | 88326 | 0.070 |
Why?
|
Quality Improvement | 4 | 2018 | 3802 | 0.070 |
Why?
|
Bacterial Toxins | 1 | 2012 | 932 | 0.070 |
Why?
|
Bacteria | 2 | 2011 | 2199 | 0.070 |
Why?
|
Enterobacteriaceae | 1 | 2007 | 161 | 0.070 |
Why?
|
Urine | 1 | 2007 | 362 | 0.070 |
Why?
|
Statistics as Topic | 1 | 2012 | 2358 | 0.070 |
Why?
|
Education, Medical, Continuing | 1 | 2011 | 823 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3688 | 0.060 |
Why?
|
Drug Utilization | 1 | 2011 | 1188 | 0.060 |
Why?
|
Amoxicillin-Potassium Clavulanate Combination | 1 | 2005 | 33 | 0.060 |
Why?
|
Proton Pump Inhibitors | 1 | 2010 | 532 | 0.060 |
Why?
|
Mice, Nude | 1 | 2011 | 3614 | 0.060 |
Why?
|
Prospective Studies | 4 | 2018 | 54423 | 0.060 |
Why?
|
Databases, Factual | 2 | 2019 | 7968 | 0.060 |
Why?
|
Neutropenia | 2 | 2019 | 885 | 0.060 |
Why?
|
Administration, Oral | 1 | 2012 | 4021 | 0.060 |
Why?
|
Biopsy | 1 | 2015 | 6766 | 0.050 |
Why?
|
Air Microbiology | 1 | 2024 | 95 | 0.050 |
Why?
|
Trimethoprim Resistance | 1 | 2003 | 4 | 0.050 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2011 | 3605 | 0.050 |
Why?
|
Quality of Health Care | 1 | 2017 | 4331 | 0.050 |
Why?
|
Patient Admission | 1 | 2010 | 1367 | 0.050 |
Why?
|
Patient Discharge | 1 | 2015 | 3443 | 0.050 |
Why?
|
Women's Health | 1 | 2012 | 2065 | 0.050 |
Why?
|
Staphylococcus | 1 | 2002 | 154 | 0.050 |
Why?
|
Monocytes | 1 | 2011 | 2570 | 0.050 |
Why?
|
Mortality | 1 | 2013 | 2902 | 0.050 |
Why?
|
DNA Damage | 1 | 2011 | 2449 | 0.050 |
Why?
|
Patient Readmission | 1 | 2015 | 3271 | 0.050 |
Why?
|
Pharmacists | 1 | 2023 | 260 | 0.050 |
Why?
|
Genome, Viral | 1 | 2024 | 667 | 0.040 |
Why?
|
Penicillins | 1 | 2023 | 402 | 0.040 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 4853 | 0.040 |
Why?
|
Biomedical Research | 1 | 2015 | 3429 | 0.040 |
Why?
|
Protective Devices | 1 | 2019 | 72 | 0.040 |
Why?
|
Bacterial Proteins | 1 | 2012 | 3847 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2017 | 5841 | 0.040 |
Why?
|
Delphi Technique | 1 | 2022 | 846 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2014 | 22176 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2012 | 5799 | 0.040 |
Why?
|
Reproducibility of Results | 2 | 2015 | 20100 | 0.040 |
Why?
|
Evaluation Studies as Topic | 1 | 2019 | 1625 | 0.030 |
Why?
|
Uropathogenic Escherichia coli | 1 | 2016 | 6 | 0.030 |
Why?
|
Electrophysiology | 1 | 2019 | 1262 | 0.030 |
Why?
|
Critical Pathways | 1 | 2020 | 474 | 0.030 |
Why?
|
Logistic Models | 1 | 2011 | 13255 | 0.030 |
Why?
|
Longitudinal Studies | 1 | 2012 | 14608 | 0.030 |
Why?
|
Cell Proliferation | 1 | 2011 | 10451 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2330 | 0.030 |
Why?
|
Diarrhea | 1 | 2022 | 1318 | 0.030 |
Why?
|
Software Design | 1 | 2015 | 171 | 0.030 |
Why?
|
Health Priorities | 1 | 2018 | 374 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 746 | 0.030 |
Why?
|
Cell Line, Tumor | 1 | 2011 | 16990 | 0.030 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2017 | 250 | 0.030 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2017 | 506 | 0.030 |
Why?
|
RNA, Viral | 1 | 2022 | 2846 | 0.030 |
Why?
|
Cross-Sectional Studies | 3 | 2023 | 26129 | 0.030 |
Why?
|
Focus Groups | 1 | 2019 | 1415 | 0.030 |
Why?
|
Workplace | 1 | 2019 | 863 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2018 | 803 | 0.030 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2014 | 238 | 0.030 |
Why?
|
Interprofessional Relations | 1 | 2018 | 990 | 0.020 |
Why?
|
Comorbidity | 2 | 2017 | 10508 | 0.020 |
Why?
|
Data Mining | 1 | 2016 | 551 | 0.020 |
Why?
|
Home Care Services | 1 | 2018 | 648 | 0.020 |
Why?
|
Animals | 2 | 2015 | 168475 | 0.020 |
Why?
|
Child | 3 | 2019 | 80158 | 0.020 |
Why?
|
Anti-Infective Agents, Local | 1 | 2011 | 247 | 0.020 |
Why?
|
Diagnostic Errors | 1 | 2016 | 1265 | 0.020 |
Why?
|
Fever | 1 | 2016 | 1618 | 0.020 |
Why?
|
Signal Transduction | 1 | 2011 | 23447 | 0.020 |
Why?
|
Infant, Newborn | 1 | 2007 | 26202 | 0.020 |
Why?
|
Pregnancy | 2 | 2019 | 29890 | 0.020 |
Why?
|
Infant | 1 | 2007 | 36193 | 0.020 |
Why?
|
Spermatocidal Agents | 1 | 2005 | 15 | 0.020 |
Why?
|
Attitude of Health Personnel | 1 | 2019 | 3889 | 0.020 |
Why?
|
Risk Assessment | 2 | 2020 | 23996 | 0.010 |
Why?
|
Child, Preschool | 1 | 2007 | 42232 | 0.010 |
Why?
|
Inpatients | 1 | 2016 | 2548 | 0.010 |
Why?
|
Mice | 1 | 2011 | 81539 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8656 | 0.010 |
Why?
|
Urinary Incontinence, Stress | 1 | 2005 | 181 | 0.010 |
Why?
|
Length of Stay | 1 | 2015 | 6426 | 0.010 |
Why?
|
Single-Blind Method | 1 | 2005 | 1574 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2020 | 39106 | 0.010 |
Why?
|
Risk | 1 | 2010 | 9610 | 0.010 |
Why?
|
Diabetes Complications | 1 | 2005 | 1315 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15843 | 0.010 |
Why?
|
Medicare | 1 | 2015 | 6770 | 0.010 |
Why?
|
Sexual Behavior | 1 | 2005 | 2180 | 0.010 |
Why?
|